International Biotechnology Trust plc (IBT.L)
GBp 708.0
(1.43%)
GBp 708.0
(1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 27.29 Million | 1.12 Million | -14.53 Million | -9.55 Million | 6.47 Million | 16.17 Million |
| Net Income | 6.93 Million | -22.32 Million | 28.04 Million | 53.59 Million | -17.44 Million | 20 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 22.06 Million | 228 Thousand | -42.41 Million | -62.97 Million | 24.01 Million | -3.79 Million |
| Other non-cash items | -1.69 Million | 23.21 Million | -162 Thousand | -170 Thousand | -96 Thousand | -48 Thousand |
| Investing Cash Flow | - | 19 Million | -43.11 Million | -64.86 Million | 25.66 Million | 6.34 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -43.11 Million | -64.86 Million | - | - |
| Sales/Maturities of investments | - | 19 Million | - | - | 25.66 Million | 6.34 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -21.38 Million | -16.41 Million | 11.99 Million | -9.1 Million | -5.35 Million | -10.13 Million |
| Debt repayment | - | - | - | -441 Thousand | - | - |
| Dividends payments | -11.4 Million | -12.87 Million | -11.56 Million | -9.54 Million | -10.61 Million | -10.13 Million |
| Common Stock Repurchased | -9.97 Million | -3.53 Million | - | -1.13 Million | - | - |
| Common Stock Issuance | - | - | 23.55 Million | 1.57 Million | 5.26 Million | - |
| Other Financing Activities | -9.97 Million | -3.53 Million | 23.55 Million | 441 Thousand | 5.26 Million | - |
| Accounts receivables | -25 Thousand | -33 Thousand | -781 Thousand | 2.45 Million | -2.56 Million | 2.78 Million |
| Accounts payables | - | 261 Thousand | 1.47 Million | -568 Thousand | 913 Thousand | -12.92 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 22.08 Million | 261 Thousand | -41.63 Million | -65.43 Million | 26.57 Million | 6.34 Million |
| Cash at beginning of period | -39.97 Million | -20.31 Million | -17.77 Million | 886 Thousand | -232 Thousand | -6.26 Million |
| Cash at end of period | -32.47 Million | -39.97 Million | -20.31 Million | -17.77 Million | 886 Thousand | -232 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 1.58 Million | -4.37 Million | - | - | - | - |
| Net cash flow / Change in cash | 7.5 Million | -19.66 Million | -2.54 Million | -18.65 Million | 1.11 Million | 6.03 Million |
| Free Cash Flow | 27.29 Million | 1.12 Million | -14.53 Million | -9.55 Million | 6.47 Million | 16.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.16 Million | 14.16 Million | -5.07 Million | 6.93 Million | -5.07 Million | 16.96 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.33 Million | -3.33 Million | 7.85 Million | 22.06 Million | 7.85 Million | -211 Thousand |
| Other non-cash items | 1.94 Million | 1.94 Million | 86 Thousand | -1.69 Million | 86 Thousand | -344 Thousand |
| Investing Cash Flow | -3.16 Million | - | - | - | - | 5.37 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.16 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 5.37 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 8.08 Million | 8.08 Million | -7.51 Million | -21.38 Million | -7.51 Million | -6.35 Million |
| Debt repayment | -28.3 Million | - | - | - | - | - |
| Dividends payments | -5.39 Million | -2.69 Million | -2.85 Million | -11.4 Million | -2.85 Million | -5.7 Million |
| Common Stock Repurchased | -3.37 Million | -3.37 Million | -4.66 Million | -9.97 Million | -4.66 Million | -646 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 14.15 Million | 14.15 Million | -4.66 Million | -9.97 Million | -4.66 Million | -323 Thousand |
| Accounts receivables | -1.75 Million | -1.75 Million | 37 Thousand | -25 Thousand | 37 Thousand | -99 Thousand |
| Accounts payables | 4.51 Million | - | - | - | - | -112 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.58 Million | -1.58 Million | 7.81 Million | 22.08 Million | 7.81 Million | 2.68 Million |
| Cash at beginning of period | -32.47 Million | - | - | -39.97 Million | -24.19 Million | -7.6 Million |
| Cash at end of period | 9.22 Million | 20.85 Million | -4.14 Million | -32.47 Million | -4.14 Million | -24.19 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -4500.00 | -4500.00 | 512 Thousand | 1.58 Million | 512 Thousand | 282 Thousand |
| Net cash flow / Change in cash | 41.7 Million | 20.85 Million | -4.14 Million | 7.5 Million | 20.05 Million | -16.58 Million |
| Free Cash Flow | 12.77 Million | 12.77 Million | 2.86 Million | 27.29 Million | 2.86 Million | 16.19 Million |
BAC-PN
HSBK
VOT
TTK
KRE
000012